Fosamax and Oesophageal carcinoma - a phase IV clinical study of FDA data

Summary:

Oesophageal carcinoma is found among people who take Fosamax, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Fosamax and have Oesophageal carcinoma. It is created by eHealthMe based on reports of 98,641 people who have side effects when taking Fosamax from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 21, 2022

98,641 people reported to have side effects when taking Fosamax.
Among them, 111 people (0.11%) have Oesophageal carcinoma.


What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 99,616 Fosamax users for its effectiveness, alternative drugs and more.

What is Oesophageal carcinoma?

Oesophageal carcinoma (cancer tumour of oesophagus) is found to be associated with 735 drugs and 387 conditions by eHealthMe.

Number of Fosamax and Oesophageal carcinoma reports submitted per year:

Could Fosamax cause Oesophageal carcinoma?

Time on Fosamax when people have Oesophageal carcinoma *:

Click here to view

Gender of people who have Oesophageal carcinoma when taking Fosamax*:

Click here to view

Age of people who have Oesophageal carcinoma when taking Fosamax *:

Click here to view

Common drugs people take besides Fosamax *:

Click here to view

Common side effects people have besides Oesophageal carcinoma *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Fosamax and have Oesophageal carcinoma?

Check whether Oesophageal carcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Oesophageal carcinoma and when was it recovered:

Expand to all the drugs that have ingredients of alendronate sodium:

Alternative drugs to, pros and cons of Fosamax:

Common Fosamax side effects:

Browse all side effects of Fosamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oesophageal carcinoma treatments and more:

COVID vaccines that are related to Oesophageal carcinoma:

Common drugs associated with Oesophageal carcinoma:

All the drugs that are associated with Oesophageal carcinoma:

Common conditions associated with Oesophageal carcinoma:

All the conditions that are associated with Oesophageal carcinoma:

How the study uses the data?

The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Fosamax) and Fosamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: